Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment
Gespeichert in:
| Veröffentlicht in: | Internal and emergency medicine 2021-03, Vol.16 (2), p.517-518 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 518 |
|---|---|
| container_issue | 2 |
| container_start_page | 517 |
| container_title | Internal and emergency medicine |
| container_volume | 16 |
| creator | Roncon, Loris Zuin, Marco Rigatelli, Gianluca |
| description | |
| doi_str_mv | 10.1007/s11739-020-02358-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7201114</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2500164823</sourcerecordid><originalsourceid>FETCH-LOGICAL-c425t-7c4f2650972885cd1d29db6adb645badf4cb3062ebd6668e175b2122d8d2fed43</originalsourceid><addsrcrecordid>eNp9UU2LFDEUDKK46-of8CANnqPJy2d7EJbBL1gQHPUa0kl6Jst0Z0x6FP31vnHWVS9CHqlQlaoHRchjzp5xxszzxrkRPWXAcISyVN4h57w3jPZC67uILVjKpDRn5EFr14wppbm5T84ECGOROCfD-ltewrYba5m6Uv2u8_OSQ_Gbww5R65bS7X1N85KO5DbhI88dnvXlhzVdlc8Uum1p-7z4Xf6RIqqXjPL2ogtlmhA9JPdGv2vp0c19QT69fvVx9ZZevX_zbnV5RYMEtVAT5Ahasd6AtSpEHqGPg_Y4Ug0-jjIMgmlIQ9Ra28SNGoADRBthTFGKC_Ly5Ls_DFOKAaNxZbevefL1uys-u3-ZOW_dpnx1Bhjn_Gjw9Magli-H1BZ3XQ51xp0dKMa4lhYEquCkCrW0VtN4m8CZO_biTr047MX96sUdrZ_8vdvtl99FoECcBA2peZPqn-z_2P4ECQWaeQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2500164823</pqid></control><display><type>article</type><title>Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment</title><source>MEDLINE</source><source>SpringerLink</source><creator>Roncon, Loris ; Zuin, Marco ; Rigatelli, Gianluca</creator><creatorcontrib>Roncon, Loris ; Zuin, Marco ; Rigatelli, Gianluca</creatorcontrib><identifier>ISSN: 1828-0447</identifier><identifier>EISSN: 1970-9366</identifier><identifier>DOI: 10.1007/s11739-020-02358-4</identifier><identifier>PMID: 32378044</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Anticoagulants ; Anticoagulants - adverse effects ; Ce - Letter to the Editor ; COVID-19 ; COVID-19 : diagnosis ; Heparin ; Heparin - adverse effects ; Humans ; Internal Medicine ; management and prognosis ; Medicine ; Medicine & Public Health ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2</subject><ispartof>Internal and emergency medicine, 2021-03, Vol.16 (2), p.517-518</ispartof><rights>Società Italiana di Medicina Interna (SIMI) 2020</rights><rights>Società Italiana di Medicina Interna (SIMI) 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c425t-7c4f2650972885cd1d29db6adb645badf4cb3062ebd6668e175b2122d8d2fed43</cites><orcidid>0000-0001-9164-9160</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11739-020-02358-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11739-020-02358-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32378044$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roncon, Loris</creatorcontrib><creatorcontrib>Zuin, Marco</creatorcontrib><creatorcontrib>Rigatelli, Gianluca</creatorcontrib><title>Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment</title><title>Internal and emergency medicine</title><addtitle>Intern Emerg Med</addtitle><addtitle>Intern Emerg Med</addtitle><subject>Anticoagulants</subject><subject>Anticoagulants - adverse effects</subject><subject>Ce - Letter to the Editor</subject><subject>COVID-19</subject><subject>COVID-19 : diagnosis</subject><subject>Heparin</subject><subject>Heparin - adverse effects</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>management and prognosis</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><issn>1828-0447</issn><issn>1970-9366</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9UU2LFDEUDKK46-of8CANnqPJy2d7EJbBL1gQHPUa0kl6Jst0Z0x6FP31vnHWVS9CHqlQlaoHRchjzp5xxszzxrkRPWXAcISyVN4h57w3jPZC67uILVjKpDRn5EFr14wppbm5T84ECGOROCfD-ltewrYba5m6Uv2u8_OSQ_Gbww5R65bS7X1N85KO5DbhI88dnvXlhzVdlc8Uum1p-7z4Xf6RIqqXjPL2ogtlmhA9JPdGv2vp0c19QT69fvVx9ZZevX_zbnV5RYMEtVAT5Ahasd6AtSpEHqGPg_Y4Ug0-jjIMgmlIQ9Ra28SNGoADRBthTFGKC_Ly5Ls_DFOKAaNxZbevefL1uys-u3-ZOW_dpnx1Bhjn_Gjw9Magli-H1BZ3XQ51xp0dKMa4lhYEquCkCrW0VtN4m8CZO_biTr047MX96sUdrZ_8vdvtl99FoECcBA2peZPqn-z_2P4ECQWaeQ</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>Roncon, Loris</creator><creator>Zuin, Marco</creator><creator>Rigatelli, Gianluca</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9164-9160</orcidid></search><sort><creationdate>20210301</creationdate><title>Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment</title><author>Roncon, Loris ; Zuin, Marco ; Rigatelli, Gianluca</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c425t-7c4f2650972885cd1d29db6adb645badf4cb3062ebd6668e175b2122d8d2fed43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Anticoagulants</topic><topic>Anticoagulants - adverse effects</topic><topic>Ce - Letter to the Editor</topic><topic>COVID-19</topic><topic>COVID-19 : diagnosis</topic><topic>Heparin</topic><topic>Heparin - adverse effects</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>management and prognosis</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roncon, Loris</creatorcontrib><creatorcontrib>Zuin, Marco</creatorcontrib><creatorcontrib>Rigatelli, Gianluca</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Internal and emergency medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roncon, Loris</au><au>Zuin, Marco</au><au>Rigatelli, Gianluca</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment</atitle><jtitle>Internal and emergency medicine</jtitle><stitle>Intern Emerg Med</stitle><addtitle>Intern Emerg Med</addtitle><date>2021-03-01</date><risdate>2021</risdate><volume>16</volume><issue>2</issue><spage>517</spage><epage>518</epage><pages>517-518</pages><issn>1828-0447</issn><eissn>1970-9366</eissn><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>32378044</pmid><doi>10.1007/s11739-020-02358-4</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0001-9164-9160</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1828-0447 |
| ispartof | Internal and emergency medicine, 2021-03, Vol.16 (2), p.517-518 |
| issn | 1828-0447 1970-9366 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7201114 |
| source | MEDLINE; SpringerLink |
| subjects | Anticoagulants Anticoagulants - adverse effects Ce - Letter to the Editor COVID-19 COVID-19 : diagnosis Heparin Heparin - adverse effects Humans Internal Medicine management and prognosis Medicine Medicine & Public Health SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 |
| title | Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A17%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Switch%20from%20oral%20anticoagulants%20to%20parenteral%20heparin%20in%20SARS-CoV-2%20hospitalized%20patients:%20comment&rft.jtitle=Internal%20and%20emergency%20medicine&rft.au=Roncon,%20Loris&rft.date=2021-03-01&rft.volume=16&rft.issue=2&rft.spage=517&rft.epage=518&rft.pages=517-518&rft.issn=1828-0447&rft.eissn=1970-9366&rft_id=info:doi/10.1007/s11739-020-02358-4&rft_dat=%3Cproquest_pubme%3E2500164823%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2500164823&rft_id=info:pmid/32378044&rfr_iscdi=true |